Real-World Safety and Effectiveness of Up to 12 Months of Tralokinumab Treatment in Adults With Atopic Dermatitis Who Discontinued Dupilumab Due to Conjunctivitis

20260 citationsJournal Articlediamond Open Access

Authors

N/A

Good health and well-being

Published in: SKIN The Journal of Cutaneous Medicine

Volume 10, Issue 2, pp. s729-s729

Field-Weighted Citation Impact: 0.00